Cathay Biotech Inc. (688065.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 33.94B |
| Enterprise Value | 25.19B |
| P/E Ratio | 61.45 |
| PEG Ratio | -9.11 |
| Price/Sales Ratio | 10.84 |
| Price/Book Ratio | 2.06 |
| Enterprise/Revenue | 8.39 |
| Enterprise/EBITDA | 31.74 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.18 |
| Operating Margin | 0.2 |
| Return On Assets | 0.02 |
| Return On Equity | 0.03 |
| Revenue | 3.3B |
| Revenue/Share | 4.71 |
| Gross Profit | 635.09M |
| EBITDA | 947.42M |
| Net Income | 565.72M |
| Diluted EPS | 0.83 |
| Total Cash | 9.41B |
| Total Cash/Share | 13.05 |
| Total Debt | 1.09B |
| Total Debt/Equity | 0.06 |
| Current Ratio | 5.11 |
| Book Value Per Share | 29.82 |
| 52-Week Change | 9.54 |
| 52-Week High | 64.5 |
| 52-Week Low | 39.51 |
| Moving Average 50 Days | 45.67 |
| Moving Average 200 Days | 50.04 |
| Average Volume | 5.64M |
| Shares Outstanding | 721.29M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.4 |
| Trailing Annual Dividend Yield | 0.78 |
| Payout Ratio | 0.02 |
| Last Split Factor | 7:5 |
| Last Split Date | July 20, 2022 |